, Tracking Stock Market Picks
Enter Symbol:
Covance Inc. (CVD) [hlAlert]

down 15.83 %

Covance Inc. (CVD) rated Underweight with price target $73 by Barclays

Posted on: Friday,  Mar 7, 2014  1:25 PM ET by Barclays

Barclays rated Underweight Covance Inc. (NYSE: CVD) on 03/07/2014. Previously Barclays rated Underweight Covance Inc. (NYSE: CVD) on 10/30/2013., when
the stock price was $89.57. Since then, Covance Inc. has gained 18.81% as of 02/18/2015's recent price of $106.42.
If you would have followed the previous Barclays's recommendation on CVD, you would have lost 15.83% of your investment in 476 days.

Covance Inc. is a leading contract research organization providing a widerange of product development services on a worldwide basis to thepharmaceutical, biotechnology and medical device industries. The company also provide health economics and outcomes services for managed care organizations, hospitals and other health care providers and laboratory testing services to the chemical, agrochemical and food industries.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/7/2014 1:25 PM Sell
102.71 73.00
as of 10/17/2014
1 Week up  0.07 %
1 Month up  8.66 %
3 Months up  9.09 %
1 YTD up  12.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2013 1:25 PM Sell
89.57 67.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy